Coherus Oncology, Inc. (CHRS)
0.99
-0.08
(-7.48%)
USD |
NASDAQ |
Oct 16, 16:00
1.01
+0.02
(+2.02%)
After-Hours: 20:00
Coherus Oncology Net Income (TTM) : -161.15M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -161.15M |
| March 31, 2026 | -172.66M |
| December 31, 2025 | -183.12M |
| September 30, 2025 | -182.87M |
| June 30, 2025 | -185.95M |
| March 31, 2025 | -195.94M |
| December 31, 2024 | -216.58M |
| September 30, 2024 | -250.14M |
| June 30, 2024 | -242.18M |
| March 31, 2024 | -230.20M |
| December 31, 2023 | -237.89M |
| September 30, 2023 | -217.11M |
| June 30, 2023 | -264.12M |
| March 31, 2023 | -271.40M |
| December 31, 2022 | -291.75M |
| September 30, 2022 | -278.61M |
| June 30, 2022 | -230.49M |
| March 31, 2022 | -210.24M |
| December 31, 2021 | -287.10M |
| September 30, 2021 | -231.67M |
| June 30, 2021 | -165.21M |
| March 31, 2021 | -76.28M |
| December 31, 2020 | 132.24M |
| September 30, 2020 | 161.76M |
| June 30, 2020 | 180.87M |
| Date | Value |
|---|---|
| March 31, 2020 | 145.41M |
| December 31, 2019 | 89.83M |
| September 30, 2019 | -11.99M |
| June 30, 2019 | -117.86M |
| March 31, 2019 | -185.11M |
| December 31, 2018 | -209.41M |
| September 30, 2018 | -195.88M |
| June 30, 2018 | -196.05M |
| March 31, 2018 | -207.77M |
| December 31, 2017 | -238.29M |
| September 30, 2017 | -265.16M |
| June 30, 2017 | -122.32M |
| March 31, 2017 | -137.07M |
| December 31, 2016 | -127.79M |
| September 30, 2016 | -104.42M |
| June 30, 2016 | -259.75M |
| March 31, 2016 | -248.64M |
| December 31, 2015 | -223.94M |
| September 30, 2015 | -200.38M |
| June 30, 2015 | -136.81M |
| March 31, 2015 | -102.85M |
| December 31, 2014 | -87.18M |
| September 30, 2014 | -72.74M |
| June 30, 2014 | -86.30M |
| March 31, 2014 | -69.94M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Enanta Pharmaceuticals, Inc. | -63.23M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |